MERIDIAN BIOSCIENCE EUROPE: what changed
What changed
MERIDIAN BIOSCIENCE EUROPE
NACE 32.500, Manufacture of medical and dental instruments and supplies
filed annual accounts (NBB)
Net result for the year
€22,729
31-12-2024 · €22,536+€193
Equity
€450,490
31-12-2024 · €454,761-€4,270
Cash
€388,342
31-12-2024 · €259,082+€129,259
Balance sheet total
€617,765
31-12-2024 · €564,687+€53,078
Largest movements
Assets
- Cash +€129,259
up €129,259 (+49.9%), from €259,082 to €388,342
mainly Receivables within one year (+€75,682) and Trade debts (+€35,220)
- Receivables within one year -€75,682
down €75,682 (-24.9%), from €304,548 to €228,866
of which Trade receivables: -€228,850
Equity and liabilities
- Trade debts +€35,220
up €35,220 (+1,282%), from €2,748 to €37,968
- Other debts +€18,946
up €18,946 (+57.3%), from €33,054 to €52,000
- Tax, wage and social debts +€8,488
up €8,488 (+12.3%), from €68,819 to €77,306
of which Remuneration and social security: +€11,055
Income statement
- Other operating charges -€7,629
no longer reported in 2025 (was €7,629)
- Depreciation +€6,219
new in 2025: €6,219
- Staff costs +€5,026
up €5,026 (+1.4%), from €364,078 to €369,104
Change in the result, 31-12-2024 to 31-12-2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 31-12-2024
€22,536
Gross operating margin
+€2,028
Staff costs
-€5,026
Depreciation
-€6,219
Other operating charges
+€7,629
Financial income
+€513
Financial charges
+€1,500
Taxes
-€232
Result 31-12-2025
€22,729
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 31-12-2024 and 31-12-2025 balance sheets and the 31-12-2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€162,477
Investment
-€6,219
Financing
-€26,999
Cash 31-12-2024
€259,082
From operations (derived)
+€162,477
Net result for the year
+€22,729
Depreciation
+€6,219
Receivables within one year
+€75,682
Deferred charges and accrued income
+€500
Trade debts
+€35,220
Tax, wage and social debts
+€8,488
Other debts
+€18,946
Accrued charges and deferred income
-€5,305
Investment (derived)
-€6,219
Investment in fixed assets (net)
-€6,219
Financing
-€26,999
Contributions, distributions and other
-€26,999
Cash 31-12-2025
€388,342
brings cash intakes cash out
Every line side by side
| Line | Code | 31-12-2024 | 31-12-2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €564,687 | €617,765 | +€53,078 | +9.4% |
| Fixed assets | 21/28 | €556 | €556 | = | 0.0% |
| Financial fixed assets | 28 | €556 | €556 | = | 0.0% |
| Current assets | 29/58 | €564,130 | €617,208 | +€53,078 | +9.4% |
| Amounts receivable within one year | 40/41 | €304,548 | €228,866 | -€75,682 | -24.9% |
| Trade receivables | 40 | €290,131 | €61,281 | -€228,850 | -78.9% |
| Other amounts receivable | 41 | €14,417 | €167,585 | +€153,168 | +1,062% |
| Cash at bank and in hand | 54/58 | €259,082 | €388,342 | +€129,259 | +49.9% |
| Deferred charges and accrued income | 490/1 | €500 | - | -€500 | |
| Total equity and liabilities | 10/49 | €564,687 | €617,765 | +€53,078 | +9.4% |
| Equity | 10/15 | €454,761 | €450,490 | -€4,270 | -0.9% |
| Contributions | 10/11 | €380,000 | €380,000 | = | 0.0% |
| Capital | 10 | €380,000 | €380,000 | = | 0.0% |
| Issued capital | 100 | €380,000 | €380,000 | = | 0.0% |
| Reserves | 13 | €70,417 | €70,417 | = | 0.0% |
| Non-distributable reserves | 130/1 | €53,318 | €53,318 | = | 0.0% |
| Legal reserve | 130 | €53,318 | €53,318 | = | 0.0% |
| Tax-exempt reserves | 132 | €17,099 | €17,099 | = | 0.0% |
| Profit (loss) carried forward | 14 | €4,344 | €74 | -€4,270 | -98.3% |
| Amounts payable | 17/49 | €109,926 | €167,274 | +€57,348 | +52.2% |
| Amounts payable within one year | 42/48 | €104,621 | €167,274 | +€62,653 | +59.9% |
| Trade debts | 44 | €2,748 | €37,968 | +€35,220 | +1,282% |
| Suppliers | 440/4 | €2,748 | €37,968 | +€35,220 | +1,282% |
| Taxes, remuneration and social security | 45 | €68,819 | €77,306 | +€8,488 | +12.3% |
| Taxes | 450/3 | €10,898 | €8,331 | -€2,567 | -23.6% |
| Remuneration and social security | 454/9 | €57,921 | €68,975 | +€11,055 | +19.1% |
| Other amounts payable | 47/48 | €33,054 | €52,000 | +€18,946 | +57.3% |
| Accrued charges and deferred income | 492/3 | €5,305 | - | -€5,305 | |
| Remuneration, social security and pensions | 62 | €364,078 | €369,104 | +€5,026 | +1.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €6,219 | +€6,219 | |
| Other operating charges | 640/8 | €7,629 | - | -€7,629 | |
| Gross operating margin | 9900 | €404,477 | €406,506 | +€2,028 | +0.5% |
| Operating profit (loss) | 9901 | €32,771 | €31,183 | -€1,588 | -4.8% |
| Financial income | 75/76B | €92 | €605 | +€513 | +559% |
| Recurring financial income | 75 | €1 | €513 | +€512 | +51,200% |
| Non-recurring financial income | 76B | €91 | €92 | +€1 | +1.1% |
| Financial charges | 65/66B | €5,155 | €3,655 | -€1,500 | -29.1% |
| Recurring financial charges | 65 | €4,019 | €3,655 | -€364 | -9.1% |
| Non-recurring financial charges | 66B | €1,135 | - | -€1,135 | |
| Profit (loss) for the period before taxes | 9903 | €27,708 | €28,133 | +€425 | +1.5% |
| Income taxes | 67/77 | €5,172 | €5,404 | +€232 | +4.5% |
| Profit (loss) for the period | 9904 | €22,536 | €22,729 | +€193 | +0.9% |
| Profit (loss) for the period to be appropriated | 9905 | €22,536 | €22,729 | +€193 | +0.9% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.